Innov Clin Neurosci. 2026;23(1–3):5–9. Dear Editor: Selective serotonin reuptake inhibitors (SSRIs) have long been a cornerstone in the treatment of mood disorders, particularly depression and anxiety. Since their introduction in
Innov Clin Neurosci. 2026;23(1–3):5–9. Dear Editor: We read with great interest the study by Fatima and Ilyas,1 which explores the relationship between ethical awareness and burnout among mental health professionals
Innov Clin Neurosci. 2026;23(1–3):5–9. Dear Editor: We thank Sah and Kumbhalwar for their careful reading of our article, “Burnout and Ethical Awareness in Mental Health Professionals: A Correlational Study,”1 and
Innov Clin Neurosci. 2026;23(1–3):5–9. Dear Editor: Pierre et al1 carefully document a case of a phenomenon that has received widespread media attention in recent months. The authors correctly note that
Dear Editor: I thank Dr. Jutla for his comments on our case report1 of artificial intelligence (AI)–associated psychosis. As we predicted, other cases have followed in the academic literature, along
Innov Clin Neurosci. 2026;23(1–3):10–16. by Larrilyn Grant, MD, MS; Lexi Singh, BS; and Anisha Mandava, MS All authors are with the Wright State, University Boonshoft School of Medicine Department of
Innov Clin Neurosci. 2026;23(1–3):17–22. by Kenny Nguyen, PharmD; Tammie Lee Demler, PharmD, MBA, BCGP, BCPP; and Eileen Trigoboff, PMHCNS-BC, DNS, DABFN Drs. Nguyen and Demler are with The New York
Innov Clin Neurosci. 2026;23(1–3):27–31. by Vatsala Sharma, MD; Vimala Sim, MD, MBA; and Maria Chona P. San Gabriel, MD, DFAPA All authors are with Department of Psychiatry, Icahn School of
Innov Clin Neurosci. 2026;23(1–3):32–38. by Humphrey Masimba Makumbirofa, MSc; Tariro Tsitsidzashe Hluyo, BPharm; Jonathan Chaweza, BTech; Simbarashe Wandayi, MVPG, BVSc; and Nyarai Desiree Soko, PhD, MSc Messrs. Makumbirofa, Hluyo, Chaweza,
Innov Clin Neurosci. 2026;23(1–3):39–46. by Steven Wickens, MPsych, and Trevor Brown, PhD Both authors are with Neurocare Group, Melbourne, Australia. FUNDING: No funding was provided for this article. DISCLOSURES: The
Innov Clin Neurosci. 2026;23(1–3):47–53. by Hamed Zarei, MD*; Mohammadhossein Vazirizadeh-Mahabadi, MD*; Narges Saadatipour, MD; Maryam Pazhooha, MD; Mostafa Hosseini, PhD; and Mahmoud Yousefifard, PhD *Drs. Zarei and Vazirizadeh-Mahabadi contributed equally
by Justin Pope, JD Mr. Pope is Associate Director of Risk Management at Professional Risk Management Services (PRMS). FUNDING: No funding was provided for the preparation of this article. DISCLOSURES:
Innov Clin Neurosci. 2025;22(10–12):14–23. by Samaneh Ghorbani Shirkouhi, MSc; Seyed Sepehr Khatami, MD; Zohair Niroomand, MD; Saeed Sadigh-Eteghad, PhD; Shahrokh Yousefzadeh-Chabok, MD; and Sasan Andalib, PhD Ms. Ghorbani Shirkouhi is
Innov Clin Neurosci. 2025;22(10–12):24–32. by Mark A. Colijn, MD, MSc, FRCPC, UCNS Dr. Colijn is with the Department of Psychiatry, Mathison Centre for Mental Health Research and Education, and Hotchkiss
Innov Clin Neurosci. 2025;22(10–12):33–51. by Franco Di Cesare, MD; Cristiana Di Carlo, MPhil; and Leonardo Di Cesare, MD All authors are with Leoben Research Aurora in San Vincenzo Valle Roveto
Innov Clin Neurosci. 2025;22(10–12):57–71. by Jayant Totlani, DO; Muhammad Arsalan Bashir, MBBS; Laurel Tay, BA; Ashley Ngor, BS; Alexander J. Steiner, PsyD; Drew Hirsch, BS; Lorena Contreras, MA; Sabrina Renteria,
Innov Clin Neurosci. 2025;22(10–12):52–56. by Alexandria Nasr, MD; Larrilyn Grant, MD; Jennifer Golida, BS; and Bailey Hangen, BS, MS All authors are affiliated with the Boonshoft School of Medicine at
Innov Clin Neurosci. 2025;22(10–12):72–77. by Anam Shahid, PhD; Alia Asmat, PhD; and Sunny Singh, MD Dr. Shahid and Dr. Singh are with the Nova Scotia Health Authority in Sydney, Nova
Innov Clin Neurosci. 2025;22(10–12):86–87. by Justin Pope, JD Mr. Pope is Associate Director of Risk Management at Professional Risk Management Services (PRMS). FUNDING: No funding was provided for the preparation
Gut Microbiota as a Therapeutic Target for Chronic Pain Disorders
Innov Clin Neurosci. 2025;23(1–3):23–26. by Takahiko Nagamine, MD, PhD Dr. Nagamine is with the Department of Psychiatric Internal Medicine, Sunlight Brain Research Center, Hofu, Japan. FUNDING: No funding was provided
Read More